Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ONC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
45 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 12 days ago
Red flags: 0
284 filers reported a long position in ONC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | $2.5B | 8.8M | 0% |
| PRIMECAP MANAGEMENT CO/CA/ | $1.4B | 5M | +0.7% |
| Capital International Investors | $1.2B | 4.2M | +1.2% |
| FMR LLC | $706.3M | 2.5M | -32.9% |
| Capital World Investors | $641.1M | 2.2M | +38.6% |
| CITADEL ADVISORS LLC | $406.2M | 1.4M | +38.1% |
| Temasek Holdings (Private) Ltd | $241M | 845.7K | -2% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $216.2M | 758.8K | +40.6% |
| BlackRock, Inc. | $197.9M | 694.6K | +5.6% |
| MILLENNIUM MANAGEMENT LLC | $154.8M | 543.3K | +165.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.